InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Schwartz Jeffrey Lawrence, Director. Insider active across 3 companies, notably SpringWorks Therapeutics, Inc.. Aggregated, 6 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €47.1m. Activity tracked since 20 May 2021. The latest transaction was disclosed on 23 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
14,300 shares0Class A Common StockSEC:0000950170-24-065323:0
4,648 shares0Common StockSEC:0000899243-23-013903:0
1,750,000 shares@ US$28.50100.0% of flowCommon StockSEC:0000899243-23-009117:0
4,818 shares0Common StockSEC:0000899243-22-019105:0
1,106 shares0Common StockSEC:0000899243-21-020446:0
1,106 shares0Common StockSEC:0000899243-21-020446
6 of 6 declarations
About Schwartz Jeffrey Lawrence
Jeffrey Lawrence Schwartz is a Board Member at SpringWorks Therapeutics, Inc. With experience in the biopharmaceutical sector, he contributes to the strategy and governance of the company. His role is essential in ensuring innovation and performance for SpringWorks.
